← Back to Search

Thrombectomy Device

Neurological Thrombectomy for Stroke

N/A
Recruiting
Research Sponsored by University at Buffalo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least 18 years of age at time of consent
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

Study Summary

This trial is testing a new device that removes clots in people with acute ischemia (lack of blood flow).

Who is the study for?
This trial is for adults over 18 who've had a stroke recently, with symptoms starting within the last 8 hours. They should have a moderate to severe stroke as measured by NIHSS (a scale used to measure stroke severity) with a score of at least 8.Check my eligibility
What is being tested?
The study is testing a new medical device designed to remove blood clots from the brain in patients experiencing an acute ischemic stroke. The goal is to see how safe and effective this thrombectomy device is when used in emergency situations.See study design
What are the potential side effects?
While specific side effects are not listed, typical risks associated with neurological thrombectomy may include bleeding in the brain, damage to blood vessels, possible allergic reactions to materials or contrast dyes used during the procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
outcomes with radiographical measurements
Secondary outcome measures
Evaluate technical efficacy outcomes with radiographical measurements

Trial Design

1Treatment groups
Experimental Treatment
Group I: neurological thrombectomy deviceExperimental Treatment1 Intervention
Revascularization device is an investigational device.

Find a Location

Who is running the clinical trial?

University at Buffalo Jacobs InstituteUNKNOWN
University at BuffaloLead Sponsor
131 Previous Clinical Trials
98,944 Total Patients Enrolled
4 Trials studying Ischemic Stroke
2,095 Patients Enrolled for Ischemic Stroke

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are we still recruiting test subjects for this experiment?

"The trial is looking for patients, as indicated by the most recent information available on clinicaltrials.gov. This entry was posted on 6/8/2021 and was last updated on 5/19/2022."

Answered by AI

How many patients qualify for this opportunity?

"The clinical trial is currently ongoing, and the most recent information available says that the study is looking for 15 patients at 1 site."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Assessing the Safety and Effectiveness of a Neurological Thrombectomy Medical Device for Acute Ischemic Stroke
Adnan H. Siddiqui 2021. "Assessing the Safety and Effectiveness of a Neurological Thrombectomy Medical Device for Acute Ischemic Stroke". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05074186.
All > Anterior Ischemic Optic Neuropathy
~2 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top